Real-world industry round-up: NICE collaborates to explore using real-world evidence to inform the cost–effectiveness of interventions

Also this month: the Alliance for Regenerative Medicine (Brussels, Belgium) has called for European action to fast-track real-world evidence use to help ensure market access to advanced therapy medicinal products, FDA’s Sentinel Program has licensed TriNetX’s (MA, USA) real-world evidence analytics suite and more! In this latest instalment of our regular monthly column, we summarize a selection of key real-world evidence industry developments that have taken place over the past month. The news highlights: NICE collaborates to explore using real-world evidence to inform the cost–effectiveness of interventions ARM calls for European action to fast-track real-world evidence use to help ensure...